403 related articles for article (PubMed ID: 17906568)
1. Enhancing effects of a prostaglandin EP4 receptor agonist on recombinant human bone morphogenetic protein-2 mediated spine fusion in a rabbit model.
Namikawa T; Terai H; Hoshino M; Kato M; Toyoda H; Yano K; Nakamura H; Takaoka K
Spine (Phila Pa 1976); 2007 Oct; 32(21):2294-9. PubMed ID: 17906568
[TBL] [Abstract][Full Text] [Related]
2. Experimental spinal fusion with recombinant human bone morphogenetic protein-2 delivered by a synthetic polymer and beta-tricalcium phosphate in a rabbit model.
Namikawa T; Terai H; Suzuki E; Hoshino M; Toyoda H; Nakamura H; Miyamoto S; Takahashi N; Ninomiya T; Takaoka K
Spine (Phila Pa 1976); 2005 Aug; 30(15):1717-22. PubMed ID: 16094272
[TBL] [Abstract][Full Text] [Related]
3. The adjunctive effect of a binding peptide on bone morphogenetic protein enhanced bone healing in a rodent model of spinal fusion.
Alanay A; Chen C; Lee S; Murray SS; Brochmann EJ; Miyazaki M; Napoli A; Wang JC
Spine (Phila Pa 1976); 2008 Jul; 33(16):1709-13. PubMed ID: 18580546
[TBL] [Abstract][Full Text] [Related]
4. Augmentation of bone morphogenetic protein-induced bone mass by local delivery of a prostaglandin E EP4 receptor agonist.
Toyoda H; Terai H; Sasaoka R; Oda K; Takaoka K
Bone; 2005 Oct; 37(4):555-62. PubMed ID: 16027058
[TBL] [Abstract][Full Text] [Related]
5. Simple carrier matrix modifications can enhance delivery of recombinant human bone morphogenetic protein-2 for posterolateral spine fusion.
Akamaru T; Suh D; Boden SD; Kim HS; Minamide A; Louis-Ugbo J
Spine (Phila Pa 1976); 2003 Mar; 28(5):429-34. PubMed ID: 12616152
[TBL] [Abstract][Full Text] [Related]
6. rhBMP-2 enhancement of posterolateral spinal fusion in a rabbit model in the presence of concurrently administered doxorubicin.
Singh K; Smucker JD; Ugbo JL; Tortolani PJ; Tsai L; Fei Q; Kuh S; Rumi M; Heller JG; Boden SD; Yoon ST
Spine J; 2007; 7(3):326-31. PubMed ID: 17482116
[TBL] [Abstract][Full Text] [Related]
7. rhBMP-6 stimulated osteoprogenitor cells enhance posterolateral spinal fusion in the New Zealand white rabbit.
Valdes M; Moore DC; Palumbo M; Lucas PR; Robertson A; Appel J; Ehrlich MG; Keeping HS
Spine J; 2007; 7(3):318-25. PubMed ID: 17482115
[TBL] [Abstract][Full Text] [Related]
8. rhBMP-2 (ACS and CRM formulations) overcomes pseudarthrosis in a New Zealand white rabbit posterolateral fusion model.
Lawrence JP; Waked W; Gillon TJ; White AP; Spock CR; Biswas D; Rosenberger P; Troiano N; Albert TJ; Grauer JN
Spine (Phila Pa 1976); 2007 May; 32(11):1206-13. PubMed ID: 17495777
[TBL] [Abstract][Full Text] [Related]
9. The effects of lentiviral gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats.
Miyazaki M; Sugiyama O; Tow B; Zou J; Morishita Y; Wei F; Napoli A; Sintuu C; Lieberman JR; Wang JC
J Spinal Disord Tech; 2008 Jul; 21(5):372-9. PubMed ID: 18600149
[TBL] [Abstract][Full Text] [Related]
10. [Experimental spinal fusion in a rabbit model with new drug delivery system for BMP].
Namikawa T; Terai H; Takaoka K
Clin Calcium; 2006 May; 16(5):793-800. PubMed ID: 16679621
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of insoluble bone gelatin as a carrier for enhancement of osteogenic protein-1-induced intertransverse process lumbar fusion in a rabbit model.
Yao G; Qian Y; Chen J; Fan Y; Stoffel K; Yao F; Xu J; Zheng MH
Spine (Phila Pa 1976); 2008 Aug; 33(18):1935-42. PubMed ID: 18708925
[TBL] [Abstract][Full Text] [Related]
12. Repair of an intercalated long bone defect with a synthetic biodegradable bone-inducing implant.
Yoneda M; Terai H; Imai Y; Okada T; Nozaki K; Inoue H; Miyamoto S; Takaoka K
Biomaterials; 2005 Sep; 26(25):5145-52. PubMed ID: 15792541
[TBL] [Abstract][Full Text] [Related]
13. [Experiment of rhBMP-2 in posterolateral spinal fusion in aged rabbits].
Duan XW; Wu H; Gu CY; Yu Y; Yang XY; Wei J; Duan DS
Zhongguo Gu Shang; 2010 Jan; 23(1):28-32. PubMed ID: 20191960
[TBL] [Abstract][Full Text] [Related]
14. In vivo evaluation of plasmid DNA encoding OP-1 protein for spine fusion.
Bright C; Park YS; Sieber AN; Kostuik JP; Leong KW
Spine (Phila Pa 1976); 2006 Sep; 31(19):2163-72. PubMed ID: 16946649
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Healos/bone marrow to INFUSE(rhBMP-2/ACS) with a collagen-ceramic sponge bulking agent as graft substitutes for lumbar spine fusion.
Kraiwattanapong C; Boden SD; Louis-Ugbo J; Attallah E; Barnes B; Hutton WC
Spine (Phila Pa 1976); 2005 May; 30(9):1001-7; discussion 1007. PubMed ID: 15864149
[TBL] [Abstract][Full Text] [Related]
16. Prostaglandin E2 EP4 agonist (ONO-4819) accelerates BMP-induced osteoblastic differentiation.
Nakagawa K; Imai Y; Ohta Y; Takaoka K
Bone; 2007 Oct; 41(4):543-8. PubMed ID: 17681894
[TBL] [Abstract][Full Text] [Related]
17. The effects of bone morphogenetic protein and basic fibroblast growth factor on cultured mesenchymal stem cells for spine fusion.
Minamide A; Yoshida M; Kawakami M; Okada M; Enyo Y; Hashizume H; Boden SD
Spine (Phila Pa 1976); 2007 May; 32(10):1067-71. PubMed ID: 17471086
[TBL] [Abstract][Full Text] [Related]
18. The effects of doxorubicin (adriamycin) on spinal fusion: an experimental model of posterolateral lumbar spinal arthrodesis.
Tortolani PJ; Park AE; Louis-Ugbo J; Attallah-Wasef ES; Kraiwattanapong C; Heller JG; Boden SD; Yoon ST
Spine J; 2004; 4(6):669-74. PubMed ID: 15541701
[TBL] [Abstract][Full Text] [Related]
19. Lumbar spinal fusion with a mineralized collagen matrix and rhBMP-2 in a rabbit model.
Liao SS; Guan K; Cui FZ; Shi SS; Sun TS
Spine (Phila Pa 1976); 2003 Sep; 28(17):1954-60. PubMed ID: 12973141
[TBL] [Abstract][Full Text] [Related]
20. Healos/recombinant human growth and differentiation factor-5 induces posterolateral lumbar fusion in a New Zealand white rabbit model.
Magit DP; Maak T; Trioano N; Raphael B; Hamouria Q; Polzhofer G; Drespe I; Albert TJ; Grauer JN
Spine (Phila Pa 1976); 2006 Sep; 31(19):2180-8. PubMed ID: 16946651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
